Loading…
Racial Differences in Blood Pressure Response to Angiotensin-Converting Enzyme Inhibitors in Children: A Meta-Analysis
Angiotensin‐converting enzyme (ACE) inhibitors are frequently used to treat hypertension in children.1 ACE inhibitors alter the balance between the vasoconstrictive, salt‐retentive, and cardiac hypertrophic properties of angiotensin II and the vasodilatory and natriuretic properties of bradykinin; t...
Saved in:
Published in: | Clinical pharmacology and therapeutics 2008-09, Vol.84 (3), p.315-319 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Angiotensin‐converting enzyme (ACE) inhibitors are frequently used to treat hypertension in children.1 ACE inhibitors alter the balance between the vasoconstrictive, salt‐retentive, and cardiac hypertrophic properties of angiotensin II and the vasodilatory and natriuretic properties of bradykinin; they also alter the metabolism of other vasoactive substances.2 Through these mechanisms, ACE inhibitors decrease systemic vascular resistance and promote natriuresis without increasing heart rate. This study evaluated the results of six trials of ACE inhibitors in children, using meta‐analytic techniques to estimate the effect of race on blood pressure response.
Clinical Pharmacology & Therapeutics (2008); 84, 3, 315–319 doi:10.1038/clpt.2008.113 |
---|---|
ISSN: | 0009-9236 1532-6535 |
DOI: | 10.1038/clpt.2008.113 |